Kerckhoff-Klinik GmbH

Bad Nauheim D-61231

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome (ACS), Angioplasty, Transluminal, Percutaneous Coronary, Aortic Valve Stenosis, CTEPH, Cardiovascular Diseases, Chronic Thromboembolic Pulmonary Hypertension, Heart Failure, Heart Failure NYHA Class III and Ambulatory IV, Heart Valve Diseases, Thrombosis, Ventricular Outflow Obstruction

Studies at this site

• Benefits of Microcor in Ambulatory Decompensated Heart Failure — Completed
• New International CTEPH Database — Completed
• International BPA Registry — Completed
• Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study) — Stopped early
• Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) — Completed
• Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D — Status unconfirmed
• A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome — Completed
• The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed